MedPath

Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids

Not Applicable
Recruiting
Conditions
Bariatric Surgery Candidate
Opioid Use, Unspecified
Interventions
Drug: Opioid based anesthesia
Drug: Opioid Free Anaesthesia
Registration Number
NCT05752799
Lead Sponsor
G.Gennimatas General Hospital
Brief Summary

The goal of this clinical trial is to compare Opioid Free and Opioid Based Anaesthesia in patients undergoing sleeve gastrectomy. The main questions it aims to answer are:

* Will the total dose of intraoperative opioid be reduced?

* Will there be difference in pain scores between groups? Participants will be managed with the Nociceptive Level Index algorithm to guide intraoperative analgesia.

The Opioid Free Anaesthesia Group will be administered the Multimix infusion (Magnesium sulfate, dexmedetomidine, ketamine). The Opioid Based Anaesthesia Group will receive fentanyl as a bolus dose and remifentanil infusion.

Rescue fentanyl bolused will be injected as appropriate according to nociceptive level (NOL) values.

Detailed Description

Opioid Free Anaesthesia has attracted the attention of clinicians since the outbreak of the opioid pandemic in the USA. It has been correlated with less intraoperative and postoperative opioid use. The Nociceptive Level Index algorithm allows for intraoperative monitoring of the nociceptive pathways and targeted pain management. Furthermore, it is known that morbidly obese patients may benefit from opioid sparing techniques.

Our aim is to investigate the effect of Opioid Free versus Opioid Based Anesthesia on postoperative pain in patients undergoing sleeve gastrectomy.

In this randomized, double blind clinical trial, patients will be allocated into two groups based on intraoperative pain management. Apart from recording postoperative pain scores, blood samples will be collected intraoperatively to evaluate the stress response among the two groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Age >18y and <75y
  • morbid obesity confirmed diagnosis
  • American Society of Anesthesiologists (ASA) II-III
  • elective laparoscopic sleeve gastrectomy surgery
  • signed informed consent
Exclusion Criteria
  • bradycardia, bundle branch block, hypotension, postural hypotension
  • obstructive sleep apnoea
  • history of depression
  • chronic corticosteroid use or intraoperative administration of more than 8mg of prednisolone or equivalent
  • refusal to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Opioid Based AnaesthesiaOpioid based anesthesiaThis arm will receive: * 2 mcg/kg fentanyl in 10 ml volume * 0.2 mL/kg/h remifentanil infusion * 0.1 mg/kg morphine
Opioid Free AnaesthesiaOpioid Free AnaesthesiaThis arm will receive * 40 mg/kg magnesium sulfate in 100 ml N/S infusion * 0.4 mcg/kg dexmedetomidine, max total dose 50mcg in 50 ml N/S infusion * 0.3 mg/kg ketamine in 10 ml volume * 0.2 ml/kg of the Multimix regimen in 100 ml N/S infusion as a bolus (The Multimix regimen consists of 50mcg dexmedetomidine, 500 mg lidocaine and 50mg ketamine). * 0.2 ml/kg/h of the Multimix regimen in 100 ml N/S infusion as a continuous infusion
Primary Outcome Measures
NameTimeMethod
Postoperative Visual Analogue Scale (VAS) score6 hours after surgery

The patient will be interviewed regarding postoperative pain using Visual Analogue Scale, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable

Secondary Outcome Measures
NameTimeMethod
First demand for supplementary analgesiaUp to 24 hours postoperatively

The time to the first demand for supplementary analgesia will be recorded for every patient enrolled.

Postoperative VAS score24 hours

The patient will be interviewed regarding postoperative pain using Visual Analogue Scale, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable

Perioperative trend of AdrenalineAt baseline, at the end of the operation, 24 hours after surgery

Blood will be collected to measure the plasma adrenaline levels

Perioperative trend of NoradrenalineAt baseline, at the end of the operation, 24 hours after surgery

Blood will be collected to measure the plasma Noradrenaline levels

Perioperative trend of CortisolAt baseline, at the end of the operation, 24 hours after surgery

Blood will be collected to measure the plasma Cortisol levels

Perioperative trend of DopamineAt baseline, at the end of the operation, 24 hours after surgery

Blood will be collected to measure the plasma Dopamine levels

Trial Locations

Locations (1)

G.Gennimatas General Hospital

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath